Ehud Keinan insider trades: Acro (ACRI) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Ehud reports to the SEC
Open-market buys and sales
1 trade reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Nov 5, 2007 | ACRI | ↑ Buy | 50,000 | $0.10 | $5K | The Shares are registered under BioTech | Nov 7, 2007 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Ehud Keinan's insider trades
Ehud Keinan is a director at Acro (ACRI). Since Nov 5, 2007, Ehud has reported 1 open-market purchase worth $5K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include other transactions (1 filing), grants and awards (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ACRI insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.